Advanced Search

Notice Of Item Numbers To Pharmaceuticals

Original Language Title: Bekendtgørelse om varenumre til lægemidler

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
Table of Contents

Appendix 1

Appendix 2

Publication of the item numbers for medicinal products 1)

In accordance with section 83 (2), 2, and section 104 (3). Three, in the law. 1180 of 12. In December 2005 on medicinal products, as amended by law no. 534 of 17. June 2008 shall be determined :

§ 1. Each individual medicinal product, the strength and the size of an approved medicinal product must be given a unique item number, cf. However, section 7.

Paragraph 2. A pharmacogalification must be provided with a new item number if the medicinal product changes its name.

Paragraph 3. A pharmacovigilance must be replaced by a new item, in the case of a change to a new holder of the marketing authorization, or if the marketing authorization holder changes his name.

Paragraph 4. The requirement for new item number in accordance with paragraph 1. 3 shall not apply where the new holder of the marketing authorisation is another undertaking within the same group, and the name of the medicinal product and the name of the marketing authorization holder shall remain unchanged. However, the only indication of the company form in the name of the marketing authorization holder shall not, however, result in a change in the item number.

Paragraph 5. The provisions of paragraph 1. 2 and 3 shall not apply to medicinal products which have a product number, but have never been placed on the market.

§ 2. An assigned item number may be used only for one marketing authorization number.

§ 3. A multipacking, that is, a packaging consisting of two or more packs of an approved medicinal product (subpacks), which are also negotiated individually, shall be considered by a separate item number.

Paragraph 2. The individual subpacks in a multigasket must be provided with a separate item number. If the sub-pacts are part of multiple packs, they must have a separate item number for each size of multi-packing.

§ 4. In the case of a medicinal product for a medicinal product for animals consisting of several inner packs, which in themselves provide the medicinal product with sufficient protection against external influences (a stork), the insides of the core may have a separate item number.

Paragraph 2. The provision in paragraph 1 shall be 1 applies only to medicinal products approved for :

1) animals whose meat or products are used for human consumption ; or

2) furry animals.

§ 5. Magistrelle medicinal products must be provided with the item number if they are listed in Annexes 1 or 2.

§ 6. The item number shall be subject to the pharmaceutical packaging in such a way that it cannot be removed.

§ 7. The product number of approved medicinal products shall be requested from the Medicinal Products Agency or an institution which is empowered by the Medicinal Products Agency for the award of the item numbers. Information on where the item numbers can be obtained may be obtained by contacting the Medicinal Products Agency.

Paragraph 2. No later than 14 days before an alert number is taken (the packing is placed on the market), this shall be reported to the Medicinal Board of Medicinal Products. This also applies to the item number for a part or inner gasket. The report shall be presented on a form which is available by way of a call to the Medicinal Board.

§ 8. The announcement does not apply to medicinal products covered by

1) the announcement of homeopathic medicinal products,

2) publication of natural medicinal products and traditional herbal medicinal products,

3) notification of radioactive medicinal products ; or

4) Notice of vitamin and minerals, etc.

§ 9. In exceptional cases, the governing board may dispense with the provisions of this notice in exceptional cases and in terms of conditions laid down in each individual case.

§ 10. The penalty shall be penalised by the penalty which is in breach of section 1 to 6 or section 7 (7). 2.

Paragraph 2. Companies can be imposed on companies. (legal persons) punishable by the rules of the penal code 5. Chapter.

§ 11. The announcement shall enter into force on 3. July, 2009.

Paragraph 2. Publication no. 961 of 26. October 2000 on the goods numbers for medicinal products are hereby repealed.

The medical board, the 29th. June 2009Jytte Lyngvig / Mette Aaboe Hansen

Appendix 1

Magistrelle medicinal products for human use which, in accordance with section 5, shall be provided with item number ;

Item Number
Medicinal Products (fer)
Mean shape
Strength
Paking Size
685008
Amphetamine
Injector fluid
50 UG/ML
10 amp. a 1 ml
685016
Amphetamine
Dropped
5 mg
10 pieces.
685024
Amphetamine
Dropped
5 mg
Twenty-five.
685032
Amphetamine
Dropped
5 mg
100.
685081
Amphetamine
Various forms
0-50 (1) / ml
685099
Amphetamine
Various forms
51-75 paragraph /ml
685107
Amphetamine
Various forms
76 (2) / ml and more
685123
Cocain
Eye drops
2%
10 ml
685131
Cocain
Eye drops
4%
10 ml
685149
Chlorpromazine hydrochloride 7 mg Pethidin hydrochloride 28 mg of Promethazine hydrochloride 7 mg
Injector fluid
2 ml
685156
Atropinsulpsulpsulp0,5 mg Morphinhydrochloride 10 mg Papaverinhydrochloride 40 mg
Dropped
100.
685164
Pethidin
Cells
50 UG/ML
30 ml
685172
Meta
Mikstur (sugar-free)
1 UG/ML
1000 ml and less
685180
Dexamphetamine
Dropped
5 mg
100.

Appendix 2

Magistrelle medicinal products for veterinary use, which shall, in accordance with section 5, be provided with item number ;

Item Number
Medicinal Products (fer)
Mean shape
Strength
Paking Size
686051
Lignocaine Hydrochloride Adrenaline
Injector fluid
20 mg +0,0125 UG/ML
100 ml
686112
Sulfathiazole
cutaneous fluid,
10%
1000 ml
686115
Megestrolacetat
tablets
5 mg
100.
686117
Salicylic Ethyl parahydroxybenzoate
cutaneous fluid,
2%5%
200 ml
686118
Salicylic Ethyl parahydroxybenzoate
cutaneous fluid,
2%5%
300 ml
686119
Salicylacityreethylparahydroxybenzoate
cutaneous fluid,
2%5%
1000 ml
686120
Salicylacityreethylparahydroxybenzoate
cutaneous fluid,
2%5%
5000 ml
686121
OxichinolinLidocainboric acid
ear drops,
0.1%1%3%
10 ml
686125
Chloramphenicol
ear drops,
10%
30 ml
686126
Calcium borogluconate
injection of injections
mg/ml.
500 ml
686133
Potassium bromide
oral solution
65 UG/ML
500 ml
686134
Sodium citrate
solution
3.8%
10 ml
686135
Sodium citrate
solution
3.8%
20 ml
686136
Caffeine
injection of injections
150 UG/ML
50 ml
686137
Apomorphinhydrochloride
injection of injections
10 UG/ML
1 ml
686138
Sulfadimidinnatrium
premix
100%
100 g
686139
Lidocainhydrochloride Norepalin
injection of injections
20 mg/ml5 mikg/ml
100 ml
686140
Lidocainhydrochloride
injection of injections
20 UG/ML
100 ml
686142
Sulfamethizole
cream
2,5%
50 ml
686143
Sodium seleneit
injection of injections
20 UG/ML
50 ml
686144
Thiaminhydrochloride
injection of injections
250 UG/ML
10 ml
686145
Magnesium trisilicate
powder, single dose tank
100 g
Paragraph 1.
686146
HydrocortisonDimethylsulfoxidMacrogol 400Macrogol 3000Propylenglycol
salve,
1%16,4% 8m1%33,1%41,4%
100 g
686147
Bismuthsubsalicylate
oral suspension,
35 UG/ML
100 ml
686148
Neostigmine
injection of injections
0.5 mg/ml
5 ml
686149
Atropin
injection of injections
1 UG/ML
10 ml
686150
Atropin
injection of injections
10 UG/ML
5 ml
686151
Kaliumiodid
powder, single dose tank
10 g
Paragraph 1.
686152
Meprobamat
tablets
400 mg
100.
686153
Levothythyroxinnatrium
tablets
0.5 mg
100.
686154
Lobeline hydrochloride
injection of injections
10 UG/ML
10 ml
686155
Sodium dioctyl sulfosuccinate
oral solution
5%
100 g
686156
Phthalylsulfathiazole
powder, single dose tank
45 g
Paragraph 1.
686157
Phytomenadion
injection of injections
25 UG/ML
10 ml
686158
Sulfacombin "Sulfacombin" SulfadiazinSulfadimidinsulfamerazinnatriumSaccharinnatriumSaccharoseCarboxymethylcelluloseslim
oral suspension,
830 mg830 mg830 mg25 mg6.3 gAd 25 ml
25 ml
686159
17-alpha-methyltestosteron Strong spirit
solution
4 mg100 ml
100 ml
686161
Acetylsalicylic acid
powder, single dose tank
2 g
Paragraph 1.
686162
Glucosamin
oral powder,
100%
50 g
686163
Glucosamin
oral powder,
100%
100 g
686164
Glucosamin
oral powder,
100%
250 g
686165
Glucosamin
oral powder,
100%
500 g
686166
Glucosamin
oral powder,
100%
1000 g
686167
Zinkoxid
premix
100%
1 kg
686168
Zinkoxid
premix
100%
5 kg
686169
Zinkoxid
premix
100%
10 kg
686170
Zinkoxid
premix
100%
25 kg
Official notes

1) The announcement has, as a draft, been notified in accordance with Directive 98 /34/EC of the European Parliament and of the Council (the Information Directive), as amended by Directive 98 /48/EC.